- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02924571
BMAC & Allograft vs BMP-2
Prospective, Blinded, Non-randomized Study of Thoracolumbar Spinal Fusion Graft Efficacy: Bone Marrow Aspirate Concentrate and Allograft Versus Recombinant Bone Morphogenetic Protein-2 (BMP)
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
New York, New York, United States, 10016
- New York University School of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Must be 18 years old or older
- Scheduled for elective posterior or anterior and posterior spinal fusion of the thoracolumbar spine with or without anterior interbody support
- Failed at least 6 weeks of conservative care
- No contraindication to BMAC (as per manufacturer)
- Signed consent form
Exclusion criteria:
- Prior lumbar fusion surgery at operative level (prior discectomy and/or laminectomy allowed)
- Incompetent or missing anterior arch at the affected level (e.g. laminectomy, pars defect)
- Currently requires laminectomy at level of surgery
- Facet joints at implant level are absent or fractured
- Post-traumatic vertebral body compromise or acute fracture at implant level
- Body mass Index (BMI) > 40
- Known allergy to titanium
- Paget's disease, osteomalacia, or any other metabolic bone disease
- Use of medications or any drug known to potentially interfere with bone/soft tissue healing (e.g. chronic systemic steroids)
- Unlikely to comply with the follow-up evaluation schedule
- Active malignancy defined as history of invasive malignancy, except if the subject has received treatment and displayed no clinical signs and symptoms for at least five years
- Pregnant or planning to become pregnant during the length of study participation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Bone Marrow Aspirate Concentrate (BMAC) + Allograft
A total of 60, 120, or 180 mL of BMA to be aspirated. BMA is then placed into the Harvest SmartPrep® Bone Marrow Concentrate (BMAC) system and concentrated to a final volume of 10, 20, or 30 mL. The BMAC will then be combined with packed allograft cancellous bone chips using the Harvest Graft Delivery Pack. The allograft bone will be obtained routinely from the bone bank in the operating suite. If using Harvest Graft Delivery Kit, the BMAC dosing estimate is as follows (BMAC to graft ratio will be 1:1):
If not using Harvest Graft Delivery Kit:
|
Allograft infused with adult stem cells from the bone marrow aspirate harvested from the iliac crest.
Harvest BMAC System delivers high stem cell concentration to the graft site.
Other Names:
|
|
Active Comparator: Recombinant Human Bone Morphogenetic Protein-2 (BMP)
12 mL BMP will be applied at the surgical site of the interbody fusion using a collagen sponge following manufacturer's directions. The BMP kit use per level is as follows:
|
INFUSE rhBMP-2 Bone Graft used according to its approved FDA labels, both from an anterior approach using titanium cages as well as from a posterior interbody approach using polyetheretherketone (PEEK) cages.
Other Names:
|
|
Active Comparator: Autograft
As per standard of care, the control group will receive 15cc - 45 cc of allograft with autograft and bone marrow aspirate at each level.
The iliac crest is the common donor site for autograft.
Using the standard technique for anterior lateral fusion, the bone graft will be laid onto the desired site of fusion.
|
Autograft with bone marrow aspirate.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Numeric Rating Scale (NRS) - Back Pain Score at Pre-Op Visit
Time Frame: Pre-Operation Visit (Day 0)
|
Participants evaluate leg and back pain using a VAS ranging from 0 cm to 10 cm.
Lower scores indicate lower levels of pain.
|
Pre-Operation Visit (Day 0)
|
|
NRS - Back Pain Score at Week 6 Follow-Up
Time Frame: Week 6 Post-Operation
|
Participants evaluate leg and back pain using a VAS ranging from 0 cm to 10 cm.
Lower scores indicate lower levels of pain.
|
Week 6 Post-Operation
|
|
NRS - Back Pain Score at Month 3 Follow-Up
Time Frame: Month 3 Post-Operation
|
Participants evaluate leg and back pain using a VAS ranging from 0 cm to 10 cm.
Lower scores indicate lower levels of pain.
|
Month 3 Post-Operation
|
|
NRS - Back Pain Score at Month 6 Follow-Up
Time Frame: Month 6 Post-Operation
|
Participants evaluate leg and back pain using a VAS ranging from 0 cm to 10 cm.
Lower scores indicate lower levels of pain.
|
Month 6 Post-Operation
|
|
NRS - Back Pain Score at Month 12 Follow-Up
Time Frame: Month 12 Post-Operation
|
Participants evaluate leg and back pain using a VAS ranging from 0 cm to 10 cm.
Lower scores indicate lower levels of pain.
|
Month 12 Post-Operation
|
|
NRS - Back Pain Score at Month 24 Follow-Up
Time Frame: Month 24 Post-Operation
|
Participants evaluate leg and back pain using a VAS ranging from 0 cm to 10 cm.
Lower scores indicate lower levels of pain.
|
Month 24 Post-Operation
|
|
Short Form 12 (SF-12) - Physical Component Summary (PCS) Score at Pre-Op Visit
Time Frame: Pre-Operation Visit (Day 0)
|
The SF-12 PCS is a physical component summary score from the Short Form 12 (SF-12) health survey.
The PCS portion of the survey comprises 6 items; the item scores are standardized to a final t-score.
The final score ranges from 0-100 with a mean of 50.
Higher scores indicate greater physical quality of life.
|
Pre-Operation Visit (Day 0)
|
|
SF-12 - PCS Score at Week 6 Follow-Up
Time Frame: Week 6 Post-Operation
|
The SF-12 PCS is a physical component summary score from the Short Form 12 (SF-12) health survey.
The PCS portion of the survey comprises 6 items; the item scores are standardized to a final t-score.
The final score ranges from 0-100 with a mean of 50.
Higher scores indicate greater physical quality of life.
|
Week 6 Post-Operation
|
|
SF-12 - PCS Score at Month 3 Follow-Up
Time Frame: Month 3 Post-Operation
|
The SF-12 PCS is a physical component summary score from the Short Form 12 (SF-12) health survey.
The PCS portion of the survey comprises 6 items; the item scores are standardized to a final t-score.
The final score ranges from 0-100 with a mean of 50.
Higher scores indicate greater physical quality of life.
|
Month 3 Post-Operation
|
|
SF-12 - PCS Score at Month 6 Follow-Up
Time Frame: Month 6 Post-Operation
|
The SF-12 PCS is a physical component summary score from the Short Form 12 (SF-12) health survey.
The PCS portion of the survey comprises 6 items; the item scores are standardized to a final t-score.
The final score ranges from 0-100 with a mean of 50.
Higher scores indicate greater physical quality of life.
|
Month 6 Post-Operation
|
|
SF-12 - PCS Score at Month 12 Follow-Up
Time Frame: Month 12 Post-Operation
|
The SF-12 PCS is a physical component summary score from the Short Form 12 (SF-12) health survey.
The PCS portion of the survey comprises 6 items; the item scores are standardized to a final t-score.
The final score ranges from 0-100 with a mean of 50.
Higher scores indicate greater physical quality of life.
|
Month 12 Post-Operation
|
|
SF-12 - PCS Score at Month 24 Follow-Up
Time Frame: Month 24 Post-Operation
|
The SF-12 PCS is a physical component summary score from the Short Form 12 (SF-12) health survey.
The PCS portion of the survey comprises 6 items; the item scores are standardized to a final t-score.
The final score ranges from 0-100 with a mean of 50.
Higher scores indicate greater physical quality of life.
|
Month 24 Post-Operation
|
|
SF-12 - Mental Component Summary (MCS) Score at Pre-Op Visit
Time Frame: Pre-Operation Visit (Day 0)
|
The SF-12 MCS is a mental component summary score from the Short Form 12 (SF-12) health survey.
The MCS portion of the survey comprises 6 items; the item scores are standardized to a final t-score.
The final score ranges from 0-100 with a mean of 50.
Higher scores indicate greater mental quality of life.
|
Pre-Operation Visit (Day 0)
|
|
SF-12 - MCS Score at Week 6 Follow-Up
Time Frame: Week 6 Post-Operation
|
The SF-12 MCS is a mental component summary score from the Short Form 12 (SF-12) health survey.
The MCS portion of the survey comprises 6 items; the item scores are standardized to a final t-score.
The final score ranges from 0-100 with a mean of 50.
Higher scores indicate greater mental quality of life.
|
Week 6 Post-Operation
|
|
Euro-Qol 5-Dimension (EQ-5D) Score at Pre-Op Visit
Time Frame: Pre-Operation Visit (Day 0)
|
5-item self-report questionnaire.
Each item describes a different aspect of health: Mobility, Self-Care, Usual Activities, Pain/Discomfort, and Anxiety/Depression.
Participants rank items on a 3-point Likert scale from 1-3: 1 = no problems; 2 = some problems; 3 = extreme problems.
The total score is the sum of responses and ranges from 5-15; lower scores indicate better overall health.
|
Pre-Operation Visit (Day 0)
|
|
EQ-5D Score at Week 6 Follow-Up
Time Frame: Week 6 Post-Operation
|
5-item self-report questionnaire.
Each item describes a different aspect of health: Mobility, Self-Care, Usual Activities, Pain/Discomfort, and Anxiety/Depression.
Participants rank items on a 3-point Likert scale from 1-3: 1 = no problems; 2 = some problems; 3 = extreme problems.
The total score is the sum of responses and ranges from 5-15; lower scores indicate better overall health.
|
Week 6 Post-Operation
|
|
EQ-5D Score at Month 3 Follow-Up
Time Frame: Month 3 Post-Operation
|
5-item self-report questionnaire.
Each item describes a different aspect of health: Mobility, Self-Care, Usual Activities, Pain/Discomfort, and Anxiety/Depression.
Participants rank items on a 3-point Likert scale from 1-3: 1 = no problems; 2 = some problems; 3 = extreme problems.
The total score is the sum of responses and ranges from 5-15; lower scores indicate better overall health.
|
Month 3 Post-Operation
|
|
EQ-5D Score at Month 6 Follow-Up
Time Frame: Month 6 Post-Operation
|
5-item self-report questionnaire.
Each item describes a different aspect of health: Mobility, Self-Care, Usual Activities, Pain/Discomfort, and Anxiety/Depression.
Participants rank items on a 3-point Likert scale from 1-3: 1 = no problems; 2 = some problems; 3 = extreme problems.
The total score is the sum of responses and ranges from 5-15; lower scores indicate better overall health.
|
Month 6 Post-Operation
|
|
EQ-5D Score at Month 12 Follow-Up
Time Frame: Month 12 Post-Operation
|
5-item self-report questionnaire.
Each item describes a different aspect of health: Mobility, Self-Care, Usual Activities, Pain/Discomfort, and Anxiety/Depression.
Participants rank items on a 3-point Likert scale from 1-3: 1 = no problems; 2 = some problems; 3 = extreme problems.
The total score is the sum of responses and ranges from 5-15; lower scores indicate better overall health.
|
Month 12 Post-Operation
|
|
EQ-5D Score at Month 24 Follow-Up
Time Frame: Month 24 Post-Operation
|
5-item self-report questionnaire.
Each item describes a different aspect of health: Mobility, Self-Care, Usual Activities, Pain/Discomfort, and Anxiety/Depression.
Participants rank items on a 3-point Likert scale from 1-3: 1 = no problems; 2 = some problems; 3 = extreme problems.
The total score is the sum of responses and ranges from 5-15; lower scores indicate better overall health.
|
Month 24 Post-Operation
|
|
Pain Catastrophizing Scale (PCS) Score at Pre-Op Visit
Time Frame: Pre-Operation Visit (Day 0)
|
Self-report questionnaire containing 13 items that describe different thoughts and feelings that may be associated with pain.
Participants rank each item on a Likert scale from 0 (not at all) to 4 (all the time).
Scores range from 0 to 52; lower scores indicate lower levels of catastrophic thinking related to pain.
|
Pre-Operation Visit (Day 0)
|
|
PCS Score at Week 6 Follow-Up
Time Frame: Week 6 Post-Operation
|
Self-report questionnaire containing 13 items that describe different thoughts and feelings that may be associated with pain.
Participants rank each item on a Likert scale from 0 (not at all) to 4 (all the time).
Scores range from 0 to 52; lower scores indicate lower levels of catastrophic thinking related to pain.
|
Week 6 Post-Operation
|
|
PCS Score at Month 3 Follow-Up
Time Frame: Month 3 Post-Operation
|
Self-report questionnaire containing 13 items that describe different thoughts and feelings that may be associated with pain.
Participants rank each item on a Likert scale from 0 (not at all) to 4 (all the time).
Scores range from 0 to 52; lower scores indicate lower levels of catastrophic thinking related to pain.
|
Month 3 Post-Operation
|
|
PCS Score at Month 6 Follow-Up
Time Frame: Month 6 Post-Operation
|
Self-report questionnaire containing 13 items that describe different thoughts and feelings that may be associated with pain.
Participants rank each item on a Likert scale from 0 (not at all) to 4 (all the time).
Scores range from 0 to 52; lower scores indicate lower levels of catastrophic thinking related to pain.
|
Month 6 Post-Operation
|
|
PCS Score at Month 12 Follow-Up
Time Frame: Month 12 Post-Operation
|
Self-report questionnaire containing 13 items that describe different thoughts and feelings that may be associated with pain.
Participants rank each item on a Likert scale from 0 (not at all) to 4 (all the time).
Scores range from 0 to 52; lower scores indicate lower levels of catastrophic thinking related to pain.
|
Month 12 Post-Operation
|
|
PCS Score at Month 24 Follow-Up
Time Frame: Month 24 Post-Operation
|
Self-report questionnaire containing 13 items that describe different thoughts and feelings that may be associated with pain.
Participants rank each item on a Likert scale from 0 (not at all) to 4 (all the time).
Scores range from 0 to 52; lower scores indicate lower levels of catastrophic thinking related to pain.
|
Month 24 Post-Operation
|
|
Length of Operation
Time Frame: Intraoperative Period (Day 0) (typically between 2-7 hours)
|
Intraoperative Period (Day 0) (typically between 2-7 hours)
|
|
|
Length of Hospital Stay
Time Frame: From admission up to discharge (Up to Year 2 Post-Operation)
|
From admission up to discharge (Up to Year 2 Post-Operation)
|
|
|
Blood Loss During Procedure
Time Frame: Intraoperative Period (Day 0) (typically between 2-7 hours)
|
Intraoperative Period (Day 0) (typically between 2-7 hours)
|
|
|
Number of Participants With Successful Fusion Status at Month 12 Post-Procedure
Time Frame: Month 12 Post-Operation
|
Fusion status assessed via CT scan by an independent radiologist.
|
Month 12 Post-Operation
|
|
Oswestry Disability Index (ODI) Score at Pre-Op Visit
Time Frame: Pre-Operation Visit (Day 0)
|
The ODI is a questionnaire used to assess the functional disability caused by low back pain.
It consists of 10 questions, each rated on a scale of 0 (none) to 5 (extreme).
The scores from the 10 questions are added up to obtain the raw score; the raw score is divided by the maximum possible score (50) and multiplied by 100 to obtain a percentage score, interpreted as follows: 0-20%: Minimal disability, 21-40%: Moderate disability, 41-60%: Severe disability, 61-80%: Crippling disability, and 81-100%: Bedridden or completely disabled.
|
Pre-Operation Visit (Day 0)
|
|
ODI Score at Week 6 Follow-Up
Time Frame: Week 6 Post-Operation
|
The ODI is a questionnaire used to assess the functional disability caused by low back pain.
It consists of 10 questions, each rated on a scale of 0 (none) to 5 (extreme).
The scores from the 10 questions are added up to obtain the raw score; the raw score is divided by the maximum possible score (50) and multiplied by 100 to obtain a percentage score, interpreted as follows: 0-20%: Minimal disability, 21-40%: Moderate disability, 41-60%: Severe disability, 61-80%: Crippling disability, and 81-100%: Bedridden or completely disabled.
|
Week 6 Post-Operation
|
|
ODI Score at Month 3 Follow-Up
Time Frame: Month 3 Post-Operation
|
The ODI is a questionnaire used to assess the functional disability caused by low back pain.
It consists of 10 questions, each rated on a scale of 0 (none) to 5 (extreme).
The scores from the 10 questions are added up to obtain the raw score; the raw score is divided by the maximum possible score (50) and multiplied by 100 to obtain a percentage score, interpreted as follows: 0-20%: Minimal disability, 21-40%: Moderate disability, 41-60%: Severe disability, 61-80%: Crippling disability, and 81-100%: Bedridden or completely disabled.
|
Month 3 Post-Operation
|
|
ODI Score at Month 6 Follow-Up
Time Frame: Month 6 Post-Operation
|
The ODI is a questionnaire used to assess the functional disability caused by low back pain.
It consists of 10 questions, each rated on a scale of 0 (none) to 5 (extreme).
The scores from the 10 questions are added up to obtain the raw score; the raw score is divided by the maximum possible score (50) and multiplied by 100 to obtain a percentage score, interpreted as follows: 0-20%: Minimal disability, 21-40%: Moderate disability, 41-60%: Severe disability, 61-80%: Crippling disability, and 81-100%: Bedridden or completely disabled.
|
Month 6 Post-Operation
|
|
ODI Score at Month 12 Follow-Up
Time Frame: Month 12 Post-Operation
|
The ODI is a questionnaire used to assess the functional disability caused by low back pain.
It consists of 10 questions, each rated on a scale of 0 (none) to 5 (extreme).
The scores from the 10 questions are added up to obtain the raw score; the raw score is divided by the maximum possible score (50) and multiplied by 100 to obtain a percentage score, interpreted as follows: 0-20%: Minimal disability, 21-40%: Moderate disability, 41-60%: Severe disability, 61-80%: Crippling disability, and 81-100%: Bedridden or completely disabled.
|
Month 12 Post-Operation
|
|
ODI Score at Month 24 Follow-Up
Time Frame: Month 24 Post-Operation
|
The ODI is a questionnaire used to assess the functional disability caused by low back pain.
It consists of 10 questions, each rated on a scale of 0 (none) to 5 (extreme).
The scores from the 10 questions are added up to obtain the raw score; the raw score is divided by the maximum possible score (50) and multiplied by 100 to obtain a percentage score, interpreted as follows: 0-20%: Minimal disability, 21-40%: Moderate disability, 41-60%: Severe disability, 61-80%: Crippling disability, and 81-100%: Bedridden or completely disabled.
|
Month 24 Post-Operation
|
|
SF-12 - MCS Score at Month 3 Follow-Up
Time Frame: Month 3 Follow-Up Post-Operation
|
The SF-12 MCS is a mental component summary score from the Short Form 12 (SF-12) health survey.
The MCS portion of the survey comprises 6 items; the item scores are standardized to a final t-score.
The final score ranges from 0-100 with a mean of 50.
Higher scores indicate greater mental quality of life.
|
Month 3 Follow-Up Post-Operation
|
|
SF-12 - MCS Score at Month 6 Follow-Up
Time Frame: Month 6 Post-Operation
|
The SF-12 MCS is a mental component summary score from the Short Form 12 (SF-12) health survey.
The MCS portion of the survey comprises 6 items; the item scores are standardized to a final t-score.
The final score ranges from 0-100 with a mean of 50.
Higher scores indicate greater mental quality of life.
|
Month 6 Post-Operation
|
|
Patient Reported Outcome Measure Information System (PROMIS) Item Bank v1.1 - Pain Interference Score at Pre-Op Visit
Time Frame: Pre-Operation Visit (Day 0)
|
40-item self-report assessing the negative effects of pain on functioning in the range experienced by the vast majority of people who have pain.
Participants rank items on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-160; lower scores indicate lower interference from pain.
The raw score is translated to give a T-score for each participant.
The T-score rescales the raw score into a standardized score ranging from 0 to 100, with a mean of 50 and a standard deviation (SD) of 10.
Higher T-scores indicate greater interference from pain.
|
Pre-Operation Visit (Day 0)
|
|
PROMIS Item Bank v1.1 - Pain Interference Score at Week 6 Follow-Up
Time Frame: Week 6 Post-Operation
|
40-item self-report assessing the negative effects of pain on functioning in the range experienced by the vast majority of people who have pain.
Participants rank items on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-160; lower scores indicate lower interference from pain.
The raw score is translated to give a T-score for each participant.
The T-score rescales the raw score into a standardized score ranging from 0 to 100, with a mean of 50 and a standard deviation (SD) of 10.
Higher T-scores indicate greater interference from pain.
|
Week 6 Post-Operation
|
|
PROMIS Item Bank v1.1 - Pain Interference Score at Month 3 Follow-Up
Time Frame: Month 3 Post-Operation
|
40-item self-report assessing the negative effects of pain on functioning in the range experienced by the vast majority of people who have pain.
Participants rank items on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-160; lower scores indicate lower interference from pain.
The raw score is translated to give a T-score for each participant.
The T-score rescales the raw score into a standardized score ranging from 0 to 100, with a mean of 50 and a standard deviation (SD) of 10.
Higher T-scores indicate greater interference from pain.
|
Month 3 Post-Operation
|
|
PROMIS Item Bank v1.1 - Pain Interference Score at Month 6 Follow-Up
Time Frame: Month 6 Post-Operation
|
40-item self-report assessing the negative effects of pain on functioning in the range experienced by the vast majority of people who have pain.
Participants rank items on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-160; lower scores indicate lower interference from pain.
The raw score is translated to give a T-score for each participant.
The T-score rescales the raw score into a standardized score ranging from 0 to 100, with a mean of 50 and a standard deviation (SD) of 10.
Higher T-scores indicate greater interference from pain.
|
Month 6 Post-Operation
|
|
PROMIS Item Bank v1.1 - Pain Interference Score at Month 12 Follow-Up
Time Frame: Month 12 Post-Operation
|
40-item self-report assessing the negative effects of pain on functioning in the range experienced by the vast majority of people who have pain.
Participants rank items on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-160; lower scores indicate lower interference from pain.
The raw score is translated to give a T-score for each participant.
The T-score rescales the raw score into a standardized score ranging from 0 to 100, with a mean of 50 and a standard deviation (SD) of 10.
Higher T-scores indicate greater interference from pain.
|
Month 12 Post-Operation
|
|
PROMIS Item Bank v1.1 - Pain Interference Score at Month 24 Follow-Up
Time Frame: Month 24 Post-Operation
|
40-item self-report assessing the negative effects of pain on functioning in the range experienced by the vast majority of people who have pain.
Participants rank items on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-160; lower scores indicate lower interference from pain.
The raw score is translated to give a T-score for each participant.
The T-score rescales the raw score into a standardized score ranging from 0 to 100, with a mean of 50 and a standard deviation (SD) of 10.
Higher T-scores indicate greater interference from pain.
|
Month 24 Post-Operation
|
|
PROMIS Scale v1.0 - Pain Intensity 3a Score at Pre-Op Visit
Time Frame: Pre-Operation Visit (Day 0)
|
3-item self-report assessment of how much a participant hurts.
Participants rank items on a 5-point Likert scale ranging from 0 (Had no pain) to 4 (Very severe).
The raw score is the sum of responses and ranges from 0-12; lower scores indicate lower levels of pain.
The raw score is translated to give a T-score for each participant.
The T-score rescales the raw score into a standardized score ranging from 0-100, with a mean of 50 and a standard deviation (SD) of 10.
Higher T-scores indicate higher intensity of pain.
|
Pre-Operation Visit (Day 0)
|
|
PROMIS Scale v1.0 - Pain Intensity 3a Score at Week 6 Follow-Up
Time Frame: Week 6 Post-Operation
|
3-item self-report assessment of how much a participant hurts.
Participants rank items on a 5-point Likert scale ranging from 0 (Had no pain) to 4 (Very severe).
The raw score is the sum of responses and ranges from 0-12; lower scores indicate lower levels of pain.
The raw score is translated to give a T-score for each participant.
The T-score rescales the raw score into a standardized score ranging from 0-100, with a mean of 50 and a standard deviation (SD) of 10.
Higher T-scores indicate higher intensity of pain.
|
Week 6 Post-Operation
|
|
PROMIS Scale v1.0 - Pain Intensity 3a Score at Month 3 Follow-Up
Time Frame: Month 3 Post-Operation
|
3-item self-report assessment of how much a participant hurts.
Participants rank items on a 5-point Likert scale ranging from 0 (Had no pain) to 4 (Very severe).
The raw score is the sum of responses and ranges from 0-12; lower scores indicate lower levels of pain.
The raw score is translated to give a T-score for each participant.
The T-score rescales the raw score into a standardized score ranging from 0-100, with a mean of 50 and a standard deviation (SD) of 10.
Higher T-scores indicate higher intensity of pain.
|
Month 3 Post-Operation
|
|
PROMIS Scale v1.0 - Pain Intensity 3a Score at Month 6 Follow-Up
Time Frame: Month 6 Post-Operation
|
3-item self-report assessment of how much a participant hurts.
Participants rank items on a 5-point Likert scale ranging from 0 (Had no pain) to 4 (Very severe).
The raw score is the sum of responses and ranges from 0-12; lower scores indicate lower levels of pain.
The raw score is translated to give a T-score for each participant.
The T-score rescales the raw score into a standardized score ranging from 0-100, with a mean of 50 and a standard deviation (SD) of 10.
Higher T-scores indicate higher intensity of pain.
|
Month 6 Post-Operation
|
|
PROMIS Scale v1.0 - Pain Intensity 3a Score at Month 12 Follow-Up
Time Frame: Month 12 Post-Operation
|
3-item self-report assessment of how much a participant hurts.
Participants rank items on a 5-point Likert scale ranging from 0 (Had no pain) to 4 (Very severe).
The raw score is the sum of responses and ranges from 0-12; lower scores indicate lower levels of pain.
The raw score is translated to give a T-score for each participant.
The T-score rescales the raw score into a standardized score ranging from 0-100, with a mean of 50 and a standard deviation (SD) of 10.
Higher T-scores indicate higher intensity of pain.
|
Month 12 Post-Operation
|
|
PROMIS Scale v1.0 - Pain Intensity 3a Score at Month 24 Follow-Up
Time Frame: Month 24 Post-Operation
|
3-item self-report assessment of how much a participant hurts.
Participants rank items on a 5-point Likert scale ranging from 0 (Had no pain) to 4 (Very severe).
The raw score is the sum of responses and ranges from 0-12; lower scores indicate lower levels of pain.
The raw score is translated to give a T-score for each participant.
The T-score rescales the raw score into a standardized score ranging from 0-100, with a mean of 50 and a standard deviation (SD) of 10.
Higher T-scores indicate higher intensity of pain.
|
Month 24 Post-Operation
|
|
PROMIS Bank v1.2 - Physical Function Score at Pre-Op Visit
Time Frame: Pre-Operation Visit (Day 0)
|
120-item self-report assessment of physical health, physical function, pain, and fatigue.
Participants rank items on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-480; lower scores indicate higher levels of physical function.
The raw score is translated to give a T-score for each participant.
The T-score rescales the raw score into a standardized score ranging from 0 to 100, with a mean of 50 and a standard deviation (SD) of 10.
Higher scores indicate greater physical function.
|
Pre-Operation Visit (Day 0)
|
|
PROMIS Bank v1.2 - Physical Function Score at Week 6 Follow-Up
Time Frame: Week 6 Post-Operation
|
120-item self-report assessment of physical health, physical function, pain, and fatigue.
Participants rank items on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-480; lower scores indicate higher levels of physical function.
The raw score is translated to give a T-score for each participant.
The T-score rescales the raw score into a standardized score ranging from 0 to 100, with a mean of 50 and a standard deviation (SD) of 10.
Higher scores indicate greater physical function.
|
Week 6 Post-Operation
|
|
PROMIS Bank v1.2 - Physical Function Score at Month 3 Follow-Up
Time Frame: Month 3 Post-Operation
|
120-item self-report assessment of physical health, physical function, pain, and fatigue.
Participants rank items on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-480; lower scores indicate higher levels of physical function.
The raw score is translated to give a T-score for each participant.
The T-score rescales the raw score into a standardized score ranging from 0 to 100, with a mean of 50 and a standard deviation (SD) of 10.
Higher scores indicate greater physical function.
|
Month 3 Post-Operation
|
|
PROMIS Bank v1.2 - Physical Function Score at Month 6 Follow-Up
Time Frame: Month 6 Post-Operation
|
120-item self-report assessment of physical health, physical function, pain, and fatigue.
Participants rank items on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-480; lower scores indicate higher levels of physical function.
The raw score is translated to give a T-score for each participant.
The T-score rescales the raw score into a standardized score ranging from 0 to 100, with a mean of 50 and a standard deviation (SD) of 10.
Higher scores indicate greater physical function.
|
Month 6 Post-Operation
|
|
PROMIS Bank v1.2 - Physical Function Score at Month 12 Follow-Up
Time Frame: Month 12 Post-Operation
|
120-item self-report assessment of physical health, physical function, pain, and fatigue.
Participants rank items on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-480; lower scores indicate higher levels of physical function.
The raw score is translated to give a T-score for each participant.
The T-score rescales the raw score into a standardized score ranging from 0 to 100, with a mean of 50 and a standard deviation (SD) of 10.
Higher scores indicate greater physical function.
|
Month 12 Post-Operation
|
|
PROMIS Bank v1.2 - Physical Function Score at Month 24 Follow-Up
Time Frame: Month 24 Post-Operation
|
120-item self-report assessment of physical health, physical function, pain, and fatigue.
Participants rank items on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-480; lower scores indicate higher levels of physical function.
The raw score is translated to give a T-score for each participant.
The T-score rescales the raw score into a standardized score ranging from 0 to 100, with a mean of 50 and a standard deviation (SD) of 10.
Higher scores indicate greater physical function.
|
Month 24 Post-Operation
|
|
PROMIS Bank v2.0 - Mobility Score at Pre-Op Visit
Time Frame: Pre-Operation Visit (Day 0)
|
15-item self-report assessment of activities of physical mobility.
Each item is ranked on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-60; lower scores indicate higher levels of physical mobility.
The raw score is translated to give a T-score for each participant.
The T-score rescales the raw score into a standardized score ranging from 0-100, with a mean of 50 and a standard deviation (SD) of 10.
Higher T-scores indicate greater physical mobility.
|
Pre-Operation Visit (Day 0)
|
|
PROMIS Bank v2.0 - Mobility Score at Week 6 Follow-Up
Time Frame: Week 6 Post-Operation
|
15-item self-report assessment of activities of physical mobility.
Each item is ranked on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-60; lower scores indicate higher levels of physical mobility.
The raw score is translated to give a T-score for each participant.
The T-score rescales the raw score into a standardized score ranging from 0-100, with a mean of 50 and a standard deviation (SD) of 10.
Higher T-scores indicate greater physical mobility.
|
Week 6 Post-Operation
|
|
PROMIS Bank v2.0 - Mobility Score at Month 3 Follow-Up
Time Frame: Month 3 Post-Operation
|
15-item self-report assessment of activities of physical mobility.
Each item is ranked on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-60; lower scores indicate higher levels of physical mobility.
The raw score is translated to give a T-score for each participant.
The T-score rescales the raw score into a standardized score ranging from 0-100, with a mean of 50 and a standard deviation (SD) of 10.
Higher T-scores indicate greater physical mobility.
|
Month 3 Post-Operation
|
|
PROMIS Bank v2.0 - Mobility Score at Month 6 Follow-Up
Time Frame: Month 6 Post-Operation
|
15-item self-report assessment of activities of physical mobility.
Each item is ranked on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-60; lower scores indicate higher levels of physical mobility.
The raw score is translated to give a T-score for each participant.
The T-score rescales the raw score into a standardized score ranging from 0-100, with a mean of 50 and a standard deviation (SD) of 10.
Higher T-scores indicate greater physical mobility.
|
Month 6 Post-Operation
|
|
PROMIS Bank v2.0 - Mobility Score at Month 12 Follow-Up
Time Frame: Month 12 Post-Operation
|
15-item self-report assessment of activities of physical mobility.
Each item is ranked on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-60; lower scores indicate higher levels of physical mobility.
The raw score is translated to give a T-score for each participant.
The T-score rescales the raw score into a standardized score ranging from 0-100, with a mean of 50 and a standard deviation (SD) of 10.
Higher T-scores indicate greater physical mobility.
|
Month 12 Post-Operation
|
|
PROMIS Bank v2.0 - Mobility Score at Month 24 Follow-Up
Time Frame: Month 24 Post-Operation
|
15-item self-report assessment of activities of physical mobility.
Each item is ranked on a 5-point Likert scale ranging from 0 to 4. The raw score is the sum of responses and ranges from 0-60; lower scores indicate higher levels of physical mobility.
The raw score is translated to give a T-score for each participant.
The T-score rescales the raw score into a standardized score ranging from 0-100, with a mean of 50 and a standard deviation (SD) of 10.
Higher T-scores indicate greater physical mobility.
|
Month 24 Post-Operation
|
|
Number of Participants Using Non-Prescription, Over-the-Counter (OTC) Drugs at Pre-Op Visit
Time Frame: Pre-Operation Visit (Day 0)
|
Number of participants taking OTC drugs for pain relief.
|
Pre-Operation Visit (Day 0)
|
|
Number of Participants Using Non-Prescription, OTC Drugs at Week 6 Follow-Up
Time Frame: Week 6 Post-Operation
|
Number of participants taking OTC drugs for pain relief.
|
Week 6 Post-Operation
|
|
Number of Participants Using Non-Prescription, OTC Drugs at Month 3 Follow-Up
Time Frame: Month 3 Post-Operation
|
Number of participants taking OTC drugs for pain relief.
|
Month 3 Post-Operation
|
|
Number of Participants Using Non-Prescription, OTC Drugs at Month 6 Follow-Up
Time Frame: Month 6 Post-Operation
|
Number of participants taking OTC drugs for pain relief.
|
Month 6 Post-Operation
|
|
Number of Participants Using Non-Prescription, OTC Drugs at Month 12 Follow-Up
Time Frame: Month 12 Post-Operation
|
Number of participants taking OTC drugs for pain relief.
|
Month 12 Post-Operation
|
|
Number of Participants Using Non-Prescription, OTC Drugs at Month 24 Follow-Up
Time Frame: Month 24 Post-Operation
|
Number of participants taking OTC drugs for pain relief.
|
Month 24 Post-Operation
|
|
Number of Participants With Surgical Complications During Operation
Time Frame: Intraoperative Period (Day 0) (typically between 2-7 hours)
|
Intraoperative Period (Day 0) (typically between 2-7 hours)
|
|
|
Number of Participants With Surgical Complications at Week 6 Follow-Up
Time Frame: Week 6 Post-Operation
|
Week 6 Post-Operation
|
|
|
Number of Participants With Surgical Complications at Month 3 Follow-Up
Time Frame: Month 3 Post-Operation
|
Month 3 Post-Operation
|
|
|
Number of Participants With Surgical Complications at Month 6 Follow-Up
Time Frame: Month 6 Post-Operation
|
Month 6 Post-Operation
|
|
|
Number of Participants With Surgical Complications at Month 12 Follow-Up
Time Frame: Month 12 Post-Operation
|
Month 12 Post-Operation
|
|
|
Number of Participants With Surgical Complications at Month 24 Follow-Up
Time Frame: Month 24 Post-Operation
|
Month 24 Post-Operation
|
|
|
SF-12 - MCS Score at Month 12 Follow-Up
Time Frame: Month 12 Post-Operation
|
The SF-12 MCS is a mental component summary score from the Short Form 12 (SF-12) health survey.
The MCS portion of the survey comprises 6 items; the item scores are standardized to a final t-score.
The final score ranges from 0-100 with a mean of 50.
Higher scores indicate greater mental quality of life.
|
Month 12 Post-Operation
|
|
SF-12 - MCS Score at Month 24 Follow-Up
Time Frame: Month 12 Post-Operation
|
The SF-12 MCS is a mental component summary score from the Short Form 12 (SF-12) health survey.
The MCS portion of the survey comprises 6 items; the item scores are standardized to a final t-score.
The final score ranges from 0-100 with a mean of 50.
Higher scores indicate greater mental quality of life.
|
Month 12 Post-Operation
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Peter Passias, NYU Langone Medical Center
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 16-01160
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spinal Fusion
-
Xtant MedicalRTI SurgicalRecruitingJoint Diseases | Musculoskeletal Diseases | Spinal Stenosis | Fusion of Spine | Spine | Spinal Fusion | Spinal Disease | Spinal Instability | Sacroiliac; Fusion | Fusion of Joint | SacroiliacUnited States, Spain, Germany
-
National Taiwan University HospitalTerminatedLumbar Fusion | Lumbar Spinal Fusion SurgeryTaiwan
-
The Second Hospital of Shandong UniversityNot yet recruiting
-
Chi Mei Medical HospitalActive, not recruiting
-
Exela Pharma Sciences, LLC.Terminated
-
Gia Dinh People HospitalCompletedSpinal FusionVietnam
-
Mayo ClinicCompleted
-
George Papanicolaou HospitalCompleted
-
AO Foundation, AO SpineRecruitingSpinal FusionUnited States, Japan, Spain, Canada, China, India, Turkey (Türkiye)
-
M.C. Kruyt, MD, PhDKuros BioSciences B.V.CompletedSpinal FusionNetherlands
Clinical Trials on Bone Marrow Aspirate Concentrate (BMAC) + Allograft
-
Weill Medical College of Cornell UniversityAclarionNot yet recruitingLow Back Pain | Lumbar Disc Herniation | Intervertebral Disc Displacement | Degenerative Disc Disease | Bone Marrow Aspirate Concentrate | DDD | CLBP - Chronic Low Back Pain | Degenerative Disc Disease, Lumbar | Disc Herniation, Lumbar | Chronic Low Back Pain (CLBP) | Degenerative Disc Disease LumbarUnited States
-
Rush University Medical CenterRecruitingOsteoarthritis of the KneeUnited States
-
NYU Langone HealthCompletedLumbar Degenerative Disc DiseaseUnited States
-
Massachusetts General HospitalRecruitingAcetabular Labrum Tear | Femoro Acetabular Impingement | Chondral Defect | Bone Marrow Aspirate ConcentrateUnited States
-
American Hip InstituteNot yet recruitingFemoroacetabular Impingement | Labral Tear
-
Bone and Joint Clinic of Baton RougeActive, not recruitingDegenerative Disc Disease | Spine DegenerationUnited States
-
Hospital for Special Surgery, New YorkEmory University; Arthritis FoundationRecruitingAnterior Cruciate Ligament Injuries | Bone Marrow Aspirate Concentrate | ACL Injury | Post-Traumatic Osteoarthritis of KneeUnited States
-
CAPRI ClinicAlberta Bone and Joint Health InstituteWithdrawnOsteoarthritis, Knee | Osteoarthritis, HipCanada
-
CELL Technologies Inc.Not yet recruitingMusculoskeletal Diseases | Knee OsteoarthritisCanada
-
Cairo UniversityRecruitingDental Implantation | Implant Site ReactionEgypt